Reuters logo
BRIEF-Arca Biopharma Inc says‍ it entered into amendment no. 1 to its capital on demand sales agreement
August 21, 2017 / 9:26 PM / in 2 months

BRIEF-Arca Biopharma Inc says‍ it entered into amendment no. 1 to its capital on demand sales agreement

Aug 21 (Reuters) - Arca Biopharma Inc:

* Arca Biopharma Inc says‍ on Aug 21, co entered into amendment no. 1 to its capital on demand sales agreement, dated as of January 11, 2017

* Arca Biopharma-‍amendment increased maximum offering value of shares of co’s stock which co may issue, sell from time to time under sales agreement​

* Amendment ‍increased maximum aggregate offering value of shares by approximately $2.9 million, from $7.3 million to $10.2 million ​ Source text: (bit.ly/2vXQUtq) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below